Monday, September 30, 2019

Top 10 pharmaceutical companies of Brazil



Top 10 pharmaceutical companies of Brazil



Brazil today stands as the sixth largest pharmaceutical market in the world, and recent forecasts suggest that it will likely reach the fifth position in the coming years. 

The top 10 pharmaceutical companies of Brazil are mentioned below are:


1.     Hypera Pharma
2.     Roche
3.     EMS
4.     Novartis
5.     Sanofi- Aventis
6.     Eurofarma
7.     Ache
8.     Laboratorio Cristalia
9.     Zoetis
10.  Biosintetica




1.      Hypera Pharma

According to 2018 statistics report Brazilian pharmaceutical company Hypera Pharma had the highest net revenue, amounting to 1.15 billion U.S. dollars.
The strength of the company in the pharmaceutical market is supported by a large-scale, low-cost operation, centralized in the largest pharmaceutical operating complex in Latin America.
Hypera Pharma is Brazil’s largest pharmaceutical company and operated into three major business units which are Branded Prescriptions, Consumer Health and Generic Prescriptions.
Branded Prescriptions operates in Primary care segments and Dermacosmetics. Branded Generics works under Neo Quimica brand which reaches more than 80% of households in Brazil

Roche stands second over 1.06 billion dollars net revenue in the year 2018. Founded in 1931, Roche's pharmaceutical division in Brazil is the sixth largest affiliate of the Group in the world with 1200 employees.
Roche Group operates majorly in two divisions: Pharmaceutical and Diagnostic. A world leader and pioneer in Hematology and oncology. Roche Diabetes Care, is the industry leader in Brazil and worldwide, offering practical, portable and patient-friendly systems, Accu-Chek. According to Roche Diabetes Care Vision, by 2025, it will help people with diabetes anywhere in the world to worry less about their daily routine so they can feel truly free, more comfortable and flexible, all day long.

EMS stands third over 1.009 billion dollars net revenue in the year 2018. Founded 50 years ago, EMS has been the leading pharmaceutical industry in Brazil for over a decade. With exports to Latin America, Europe, Africa, Asia and the Middle East, EMS is present in over 40 countries. 
Cyclosporine Microemulsion, an immunosuppressant used to combat organ rejection, is one of the main exported drugs. One of the largest sales forces with about 1500 medical professionals and 5000 employees throughout Brazil. EMS operates in the areas of Prescription, generic, Branded, OTC and hospital medicines and has the largest portfolio in Brazil among anti-inflammatory, analgesic, antibiotic, antiulcer, antihypertensive, anthelmintic, anti-diabetic, topical and anti-influenza corticosteroids.  EMS has been the only manufacturer of the generic product in all of Latin America for over 16 years. 

Novartis stands third over 0.91 billion dollars net revenues in 2018. For over 80 years in Brazil, Novartis has 2,700 employees and focuses on innovation.  Over the past three years, it has benefited over 30,000 patients in over 300 research centers in Brazil. Novartis Group has two manufacturing units in Brazil that operates in the production of pharmaceutical products for the treatment of glaucoma and post-surgery. Novartis’ Sandoz division is a global leader in the generic and biosimilar industry.
Novartis was elected among the Most Admired Companies in Brazil since 1997. 
5.      Sanofi- Aventis
Another major player is Sanofi Aventis with 0.86 billion dollars net revenue in the year 2018. Over-the-counter medications and consumer products are one of Sanofi's main lines of activity in Brazil. It has a diverse portfolio for treatments in therapeutic areas such as inflammation, diabetes, cardiovascular disease and diabetes and chronic diseases.
In Brazil, Sanofi carries out collaborative projects with universities, clinical research support and public-private partnerships for the development of drugs, therapies and vaccines relevant to the population.

6.      Eurofarma
Eurofarma stands 5th with 0.78 billion dollars net revenue in the year 2018. Products originating in partnerships and licenses currently account for about 3% of the company’s total revenue. Front runners in the Prescription Drugs, Generic Drugs, Hospital, Oncology, Nonprescription Drugs and Veterinary Medicine segments, central nervous system (CNS), anti-infective and hormonal drugs.
Eurofarma was the only company in Brazil to launch first generic oncological product in the early 2000s. In the year 2018 it provided the market with the first biosimilar drug in Latin America – Fiprima® (filgrastim), a drug used to induce an increase in the body’s defense cells for patients with some types of cancer. The company stands tall with many awards and certifications.

7.      Ache
Ache contributes to 0.69 billion dollars net revenue in 2018. With 4,700 employees and always attentive to the issue of diversity, 52% of its employees are women. The company has a broad and diversified portfolio, consisting of 358 brands and 145 therapeutic classes, in the prescription, generic, over-the-counter (OTC), dermocosmetics, dermatological drugs, nutraceuticals, probiotics and biotechnology.
The biggest patient support program, Cuidados Pela Vida (CPV) organized by Ache, which provides patients an access to different medicines, treatment adherence through discounts. The program also offers services such as health reminders sent via SMS text, 24/7 Nursing Center, for clarifying doubts, web shopping, delivering medicines at home and periodically updating health and well-being.

Another major player in the Brazil’s pharmaceutical market is Laboratório Cristália. Founded in 2002, Latinofarma was acquired by Cristália in 2015.
The only one in Brazil capable of developing the entire drug chain, from the molecule conception to the final product. Laboratorio Cristalia has 2,500 workers in Brazil, distributed in 5 main units in the city of Sao Paulo.

9.      Zoetis
The only company in Brazil which deals with animal health products. It also conducts various learning programs for the veterinarians. It specializes in antibiotic drugs for the animals.

Biosintética, Ache’s generic drug brand  is among the first brands to obtain generic registrations in Brazil. It generated 0.26 billion dollars net revenues for the year 2018.



No comments:

Post a Comment

Biocon Ltd recibió una carta de advertencia de la FDA

El regulador de salud de EE. UU. Realizó una inspección previa a la aprobación y un examen de buenas prácticas de fabricación (BPF) de la...

popad